Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02013427 · ClinicalTrials.gov registry record · Phase 4
Placebo In Chronic Back Pain - Double-Blind Randomized Control Trial
A Phase 4 study, sponsored by Northwestern University.
- Completed
- Registry status
- Phase 4
- Development phase
- 82
- Enrollment target
NCT02013427 is a Phase 4 study that has completed, run by Northwestern University. The registered enrollment target is 82 participants.
The verdict
NCT02013427, a Phase 4 study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 82 participants
- Enrollment target
Study Summary
This study is designed to examine brain properties for placebo response in chronic back pain patients. The investigators have preliminary data indicating that, in blinded clinical trial studies with neutral instructions regarding treatment, chronic back pain (CBP) patients can be subdivided into placebo responders and non-responders, and these differences are PREDICTABLE a priori, by brain activity. The results imply that CBP placebo may have clinical utility and that its properties can be studied by human brain imaging techniques. In Phase I of the study, the investigators seek to identify brain imaging parameters that predict the propensity for the placebo response in an independent CBP cohort. In Phase II, the investigators will evaluate the interaction between placebo response and medication treatment in individuals stratified as placebo responders versus non-responders. This research is designed to critically assess the neurobiology of placebo analgesia for chronic pain in a partially-blind clinical trial.
Interventions
- DRUG Placebo
- DRUG Omeprazole
- DRUG Naproxen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 82 participants |
| Start Date | 2014-10 |
| Est. Completion | 2016-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02013427
The ClinicalTrials.gov registry entry for NCT02013427 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 82 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT02013427 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02013427 about?
NCT02013427 is a clinical study titled "Placebo In Chronic Back Pain - Double-Blind Randomized Control Trial". This study is designed to examine brain properties for placebo response in chronic back pain patients. The investigators have preliminary data indicating that, in blinded clinical trial studies with neutral instructions regarding treatment, chronic back pain (CBP) patients can be subdivided into pla...
What is the current status of trial NCT02013427?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 82 participants. The study started on 2014-10. Estimated completion is 2016-05.
What interventions are being tested in trial NCT02013427?
The interventions under investigation include: Placebo (DRUG), Omeprazole (DRUG), Naproxen (DRUG).
Who is sponsoring clinical trial NCT02013427?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.